Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.3336
-0.0156 (-4.47%)
At close: Nov 16, 2026, 4:00 PM EST
0.3330
-0.0006 (-0.18%)
After-hours: Nov 16, 2026, 7:57 PM EST

Tenaya Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
22.4824.7229.2133.1631.0818.41
Research & Development
61.1168.6186.7498.0494.5454.39
Operating Expenses
83.5993.33115.95131.19125.6272.81
Operating Income
-80.56-93.33-115.95-131.19-125.62-72.81
Interest & Investment Income
2.72.684.747.061.950.11
Other Non Operating Income (Expenses)
0.020.050.080.050-0.02
EBT Excluding Unusual Items
-77.83-90.6-111.13-124.08-123.67-72.72
Gain (Loss) on Sale of Assets
-0.09-----
Other Unusual Items
-1.37-----
Pretax Income
-101.78-90.6-111.13-124.08-123.67-72.72
Net Income
-101.78-90.6-111.13-124.08-123.67-72.72
Net Income to Common
-101.78-90.6-111.13-124.08-123.67-72.72
Net Income Growth
------
Shares Outstanding (Basic)
20915385744518
Shares Outstanding (Diluted)
20915385744518
Shares Change
59.82%80.34%14.96%64.61%152.75%1724.33%
EPS (Basic)
-0.49-0.59-1.31-1.68-2.76-4.10
EPS (Diluted)
-0.49-0.59-1.31-1.68-2.76-4.10
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-54.65-68.88-91.53-103.31-125.05-85.93
Free Cash Flow Per Share
-0.26-0.45-1.08-1.40-2.79-4.85
EBITDA
-74.88-84.9-107.48-122.51-119.15-69.85
D&A For EBITDA
5.688.448.478.696.472.96
EBIT
-80.56-93.33-115.95-131.19-125.62-72.81
SEC Filings: 10-K · 10-Q